SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    How tobacco companies are thinking about the cannabis industry

    By

    On this episode of BofC Live, we connect with Barbara Pastori, Director of Strategy and Data for Prohibition Partners. Last week, Pastori penned a piece titled: Is cannabis the future for big tobacco? describing the alignment between big tobacco’s stated corporate goals and cannabis industry opportunities. Read the full piece.

    The global exodus of consumers from the tobacco market means this industry is now at a turning point, where alternative or additional product lines are vital to the future security of its companies. Among the many alternatives that the tobacco industry is exploring as part of its broad reimagining of its future, cannabis surely represents an opportunity. Numerous tobacco companies have already made investments in the cannabis industry over the past few years, including Altria, Imperial Brands, and most recently British American Tobacco.

    – Barbara Pastori, Director of Strategy and Data, Prohibition Partners

    BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector.


    Listen to this episode of BofC Live, and all BofC Live episodes, as a podcast:

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    BofC

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free